Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia

dc.authorid0000-0003-4815-3674
dc.authorid0000-0002-2048-4992
dc.contributor.authorSatman, Ilhan
dc.contributor.authorDayican, Damla Korkmaz
dc.contributor.authorCalikoglu, Fulya
dc.contributor.authorSahin, Humeyra Rekali
dc.contributor.authorPerone, Francesco
dc.contributor.authorAkinci, Buket
dc.date.accessioned2025-10-06T11:05:13Z
dc.date.available2025-10-06T11:05:13Z
dc.date.issued2025
dc.departmentMeslek Yüksekokulları, Meslek Yüksekokulu, Fizyoterapi Programı
dc.description.abstractBackground Diabetic dyslipidemia, a common comorbidity in people with type 2 diabetes, has been reported to be associated with adverse metabolic outcomes. Skeletal muscle is a key organ impacted by metabolic disorders; however, the specific effects of diabetic dyslipidemia on skeletal muscle mass, strength, and performance remain unclear. The aim of this study was to assess the skeletal muscle alterations of people with type 2 diabetes with and without dyslipidemia. Methods This retrospective study included 144 participants (mean age 51.3 +/- 7.1 years; 103 female, 41 male) aged 40-65 years. Body composition was assessed using bioelectrical impedance analysis (BIA), muscle strength via dynamometer, and functional capacity with the 6-minute walk test (6MWT). To minimize the confounding effect of longer diabetes duration in the diabetic dyslipidemia group, propensity score matching (PSM) was performed using a 1:1 nearest-neighbor method. All analyses were performed on matched groups. ROC analysis was conducted for variables showing significant differences. Results After PSM, people with diabetic dyslipidemia showed significantly lower skeletal muscle mass and skeletal muscle index (SMI), higher body fat percentage, and reduced 6MWD compared to those with diabetes alone (p < 0.05). In women with diabetic dyslipidemia, handgrip strength was significantly lower. ROC analysis revealed moderate predictive value for skeletal muscle mass (AUC = 0.682), SMI (AUC = 0.654), and 6MWD (AUC = 0.628). Conclusion This study demonstrated that people with diabetic dyslipidemia had lower skeletal muscle mass, SMI, and decreased physical performance compared to people with diabetes alone, even after matching for diabetes duration. These findings demonstrate early sarcopenic and dynapenic changes and highlight the need to consider skeletal muscle health and lipid abnormalities together in diabetes management.
dc.identifier.citationYigit, S., Eksi, B. U., Satman, I., Dayican, D. K., Calikoglu, F., Sahin, H. R., … Akinci, B. (2025). Skeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia. Lipids in Health and Disease, 24(1). ‌
dc.identifier.doiDOI: 10.1186/s12944-025-02701-8
dc.identifier.endpage9
dc.identifier.issn1476511X
dc.identifier.issue1
dc.identifier.pmid40988050
dc.identifier.scopus2-s2.0-105016856809
dc.identifier.scopusqualityQ2
dc.identifier.scopusqualityQ2
dc.identifier.scopusqualityQ2
dc.identifier.scopusqualityQ2
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/20.500.12941/328
dc.identifier.volume24
dc.identifier.wosWOS:001578589400001
dc.identifier.wosqualityQ1
dc.identifier.wosqualityQ2
dc.indekslendigikaynakScopus
dc.indekslendigikaynakScopus
dc.indekslendigikaynakScopus
dc.indekslendigikaynakScopus
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakWeb of Science
dc.institutionauthorEksi, Büşra Ülker
dc.institutionauthorYiğit, Şafak
dc.institutionauthorid0000-0003-4815-3674
dc.institutionauthorid0000-0002-2048-4992
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofLipids in Health and Disease
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectType 2 diabetes
dc.subjectDyslipidemia
dc.subjectSkeletal muscle
dc.subjectSarcopenia
dc.subjectTip 2 diyabet
dc.subjectDislipidemi
dc.subjectİskelet kası
dc.subjectSarkopeni
dc.titleSkeletal muscle alterations in type 2 diabetes mellitus with and without dyslipidemia
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
BüşraÜlkerEKşi-ŞafakYiğit.pdf
Boyut:
1.69 MB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: